THERAPEUTICSMD INC - COM (TXMD)

CUSIP: 88338N107

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Equity / COM
Total 13F shares
155,172,033
Share change
-5,010,570
Total reported value
$1,056,251,015
Put/Call ratio
0%
Price per share
$6.81
Number of holders
134
Value change
-$38,331,278
Number of buys
70
Number of sells
51

Quarterly Holders Quick Answers

What is CUSIP 88338N107?
CUSIP 88338N107 identifies TXMD - THERAPEUTICSMD INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERAPEUTICSMD INC - COM (TXMD) as of Q3 2016

As of 30 Sep 2016, THERAPEUTICSMD INC - COM (TXMD) was held by 134 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 155,172,033 shares. The largest 10 holders included FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, Bank of New York Mellon Corp, WELLINGTON MANAGEMENT GROUP LLP, JPMORGAN CHASE & CO, FRANKLIN RESOURCES INC, VANGUARD GROUP INC, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., and GILDER GAGNON HOWE & CO LLC. This page lists 134 institutional shareholders reporting positions in this security for the Q3 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.